Question 1

Who owns INBS?

Accepted Answer

INTELLIGENT BIO SOLUTIONS IN (INBS) is held by 6 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is Alyeska Investment Group, L.P. as of Q1 2026.

Question 2

Are institutions buying or selling INBS?

Accepted Answer

In Q1 2026, 5 institutions opened or increased positions in INTELLIGENT BIO SOLUTIONS IN while 4 reduced or exited — a net buying quarter.

Question 3

What is the Smart Money Verdict on INBS?

Accepted Answer

The Smart Money Verdict combines four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for INTELLIGENT BIO SOLUTIONS IN.

Question 4

How many hedge funds hold INBS?

Accepted Answer

6 institutional investors report holding INTELLIGENT BIO SOLUTIONS IN (INBS) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into INBS?

Accepted Answer

As of Q1 2026, tracked institutions in INTELLIGENT BIO SOLUTIONS IN show 5 buyers versus 4 sellers — net inflows.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
AIAlyeska Investment Group, L.P.	New	37,956	$126,963	0.0%	-47.32%	31
GEODE CAPITAL MANAGEMENT, LLC	New	28,609	$95,696	0.0%	-47.32%	33
VAVANGUARD CAPITAL MANAGEMENT LLC	New	5,810	$19,434	0.0%	-47.32%	29
VFVANGUARD FIDUCIARY TRUST CO	New	3,958	$13,240	0.0%	-47.32%	27
UBS Group AG	Decreased	372(-90.8%)	$1,244	0.0%	-47.32%	0
OSAIC HOLDINGS, INC.	New	200	$670	0.0%	-47.32%	17
BANK OF AMERICA CORP /DE/	Exited	0(-100.0%)	$86	0.0%	-71.35%	0
CITIGROUP INC	Exited	0(-100.0%)	$724	0.0%	-64.04%	0
NATIONAL BANK OF CANADA /FI/	Exited	0(-100.0%)	$332	0.0%	-73.20%	0

INTELLIGENT BIO SOLUTIONS IN

Continue exploring

Other Healthcare stocks held by institutions